Rabbit anti-Human MED23 Polyclonal Antibody

Beta LifeScience SKU/CAT #: BLC-05218A
Western blot analysis of extracts from A549 cells, using MED23 antiobdy.
Western blot analysis of extracts from A549 cells, using MED23 antiobdy.
Immunohistochemistry analysis of paraffin-embedded human colon carcinoma tissue, using MED23 antibody.
Immunohistochemistry analysis of paraffin-embedded human colon carcinoma tissue, using MED23 antibody.
Immunofluorescence analysis of A549 cells, using MED23 antibody.
Immunofluorescence analysis of A549 cells, using MED23 antibody.

Rabbit anti-Human MED23 Polyclonal Antibody

Beta LifeScience SKU/CAT #: BLC-05218A
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.

Product Overview

Product Title Rabbit anti-Human MED23 Polyclonal Antibody
Description The antibody against MED23 was raised in rabbit using the Synthesized peptide derived from internal of Human MED23. as the immunogen. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This antibody has been validated on ELISA, WB, IHC, IF.
Uniprot Id - Alink Q9ULK4
Host Species Rabbit
Reactivity Human, Mouse
Target Name MED23
Target Synonyms 130 kDa transcriptional co activator antibody; 133 kDa transcriptional co activator antibody; Activator recruited cofactor 130 kDa component antibody; Activator-recruited cofactor 130 kDa component antibody; ARC 130 antibody; ARC130 antibody; Cofactor required for Sp1 transcriptional activation subunit 3 130kDa antibody; Cofactor required for Sp1 transcriptional activation subunit 3 130kDa mediator antibody; Cofactor required for Sp1 transcriptional activation subunit 3 antibody; CRSP 130 antibody; CRSP 130 kD subunit antibody; CRSP 133 antibody; CRSP 3 antibody; CRSP complex subunit 3 antibody; CRSP130 antibody; CRSP133 antibody; CRSP3 antibody; CRSP3 protein antibody; DKFZp434H0117 antibody; DRIP 130 antibody; DRIP130 antibody; hSur-2 antibody; KIAA1216 antibody; MED 23 antibody; med23 antibody; MED23_HUMAN antibody; Mediator complex subunit 23 antibody; Mediator of RNA polymerase II transcription subunit 23 antibody; MRT18 antibody; Protein sur-2 homolog antibody; SUR 2 antibody; SUR2 antibody; Transcriptional co activator CRSP 130 antibody; Transcriptional co activator CRSP130 antibody; Transcriptional coactivator CRSP130 antibody; Vitamin D3 receptor interacting protein antibody; Vitamin D3 receptor interacting protein complex 130 kDa component antibody; Vitamin D3 receptor-interacting protein complex 130 kDa component antibody
Immunogen Description Synthesized peptide derived from internal of Human MED23.
Immunogen Species Human
Immunogen Sequence Complete sequences for the immunogen, target protein, and peptides are available upon request.
Clonality Polyclonal
Purification Method The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Buffer Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Form Liquid
Application ELISA, WB, IHC, IF
Storage Conditions Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

FAQs

Please fill out the Online Inquiry form located on the product page. Key product information has been pre-populated. You may also email your questions and inquiry requests to sales1@betalifesci.com. We will do our best to get back to you within 4 business hours.

Feel free to use the Chat function to initiate a live chat. Our customer representative can provide you with a quote immediately.

Proteins are sensitive to heat, and freeze-drying can preserve the activity of the majority of proteins. It improves protein stability, extends storage time, and reduces shipping costs. However, freeze-drying can also lead to the loss of the active portion of the protein and cause aggregation and denaturation issues. Nonetheless, these adverse effects can be minimized by incorporating protective agents such as stabilizers, additives, and excipients, and by carefully controlling various lyophilization conditions.

Commonly used protectant include saccharides, polyols, polymers, surfactants, some proteins and amino acids etc. We usually add 8% (mass ratio by volume) of trehalose and mannitol as lyoprotectant. Trehalose can significantly prevent the alter of the protein secondary structure, the extension and aggregation of proteins during freeze-drying process; mannitol is also a universal applied protectant and fillers, which can reduce the aggregation of certain proteins after lyophilization.

Our protein products do not contain carrier protein or other additives (such as bovine serum albumin (BSA), human serum albumin (HSA) and sucrose, etc., and when lyophilized with the solution with the lowest salt content, they often cannot form A white grid structure, but a small amount of protein is deposited in the tube during the freeze-drying process, forming a thin or invisible transparent protein layer.

Reminder: Before opening the tube cap, we recommend that you quickly centrifuge for 20-30 seconds in a small centrifuge, so that the protein attached to the tube cap or the tube wall can be aggregated at the bottom of the tube. Our quality control procedures ensure that each tube contains the correct amount of protein, and although sometimes you can't see the protein powder, the amount of protein in the tube is still very precise.

To learn more about how to properly dissolve the lyophilized recombinant protein, please visit Lyophilization FAQs.

Recently viewed